Clinical trial
GUo's Renovisceral Artery Reconstruction-2: a Prospective,Single Center,Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a multibRANched sTEnt Graft systEm for Thoracoabdominal Aortic Aneurysm
NCT06478576 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GUo's Renovisceral Artery Reconstruction-2: a Prospective,Single Center,Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a multibRANched sTEnt Graft systEm for Thoracoabdominal Aortic Aneurysm
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2023
- Completion date
- May 30, 2028
- Enrollment
- 73 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thoracoabdominal aortic aneurysm